| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01XK01 | B | Olaparib - 150mg | 10372/388 | 70020/1 | LYNPARZA | 150mg | 56 | Tablet, film coated | Oral | Omnipharma | Abbvie Ltd | USA | L.L | 2.44 | E2 | AstraZeneca UK Ltd | UK | 10/3/202 |
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01XK01 | B | Olaparib - 150mg | 10372 | 70020/1 | LYNPARZA | 150mg | 56 | Tablet, film coated | Oral | Omnipharma | Abbvie Ltd | USA | 230,789,350 L.L | 2.44 | E2 | AstraZeneca UK Ltd | UK | 10/3/202 |

